Rocket One Inc. Realized Gains on Marketable Securities
Rocket One Inc. (RKTO) reported Realized Gains on Marketable Securities of -$567.69 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesRealizedGainLoss · last filed 2023-03-31
- Rocket One Inc. marketable securities, realized gain (loss) for the quarter ending 2022-12-31 was -$373.51K.
- Rocket One Inc. marketable securities, realized gain (loss) for the quarter ending 2022-09-30 was $0.00.
- Rocket One Inc. marketable securities, realized gain (loss) for the quarter ending 2021-12-31 was -$10.00, a 100.10% decline year-over-year.
- Rocket One Inc. marketable securities, realized gain (loss) for the quarter ending 2021-09-30 was -$41.21K.
- Rocket One Inc. marketable securities, realized gain (loss) for fiscal 2022 was -$567.69K.
- Rocket One Inc. marketable securities, realized gain (loss) for fiscal 2021 was -$41.81K.
- Rocket One Inc. marketable securities, realized gain (loss) for fiscal 2020 was -$1.18K.
| Period end | Marketable Securities, Realized Gain (Loss) 3 month | Marketable Securities, Realized Gain (Loss) 6 month | Marketable Securities, Realized Gain (Loss) 9 month | Marketable Securities, Realized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$373.51K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$373.51K derived: sum of 2 quarters · filed 2023-03-31 | -$567.69K 10-K · filed 2023-03-31 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$194.18K 10-Q · filed 2022-11-10 | ||
| 2022-06-30 | -$194.18K 10-Q · filed 2022-08-12 | |||
| 2021-12-31 | -$10.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$41.22K derived: sum of 2 quarters · filed 2023-03-31 | -$75.14K derived: sum of 3 quarters · filed 2023-03-31 | -$41.81K 10-K · filed 2023-03-31 |
| 2021-09-30 | -$41.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$75.13K derived: sum of 2 quarters · filed 2022-11-10 | -$41.80K 10-Q · filed 2022-11-10 | -$31.91K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$33.91K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$584.00 10-Q · filed 2022-08-12 | $9.30K derived: sum of 3 quarters · filed 2022-08-12 | -$6.65K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $33.33K 10-Q · filed 2022-05-12 | $43.21K derived: sum of 2 quarters · filed 2022-05-12 | $27.26K derived: sum of 3 quarters · filed 2022-05-12 | $27.26K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $9.88K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$6.07K derived: sum of 2 quarters · filed 2022-03-30 | -$6.07K derived: sum of 3 quarters · filed 2022-03-30 | -$1.18K 10-K · filed 2022-03-30 |
| 2020-09-30 | -$15.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$15.95K derived: sum of 2 quarters · filed 2021-11-10 | -$11.06K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $4.89K 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | $4.89K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |